Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.

Wing Ying Au Chengjin Ye Sydney Leigh Briner Gianmarco Domenico Suarez Jeewon Han Xinzhou Xu Jun-Gyu Park Melinda Ann Brindley Luis Martinez-Sobrido Peter Pak-Hang Cheung

J Infect

Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Li Ka Shing Medical Sciences Building, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China. Electronic address:

Published: May 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889726	PMC
http://dx.doi.org/10.1016/j.jinf.2022.02.030	DOI Listing

Publication Analysis

Top Keywords

systematic comparison

comparison bnt162b2

bnt162b2 coronavac

coronavac seroprotection

seroprotection sars-cov-2

sars-cov-2 alpha

alpha beta

beta gamma

gamma delta

delta variants

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!